Ollen Pharma Trading Inc Pharmaceutical Import Profile — Philippines (DGFT 2022–2026)

Name: Ollen Pharma Trading Inc Pharmaceutical Import Records from India — 4 Products, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Ollen Pharma Trading Inc — Pharmaceutical Importer Profile (2026) | 4 Products, $1.9M Trade | TransData Nexus

Ollen Pharma Trading Inc

Pharmaceutical Importer · Philippines · Respiratory Focus · $1.9M Total Trade · DGFT Verified

Ollen Pharma Trading Inc is a pharmaceutical importer based in Philippines with a total trade value of $1.9M across 4 products in 4 therapeutic categories. Based on 198 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Ollen Pharma Trading Inc sources from 10 verified Indian suppliers, with Althea Pharma Private Limited accounting for 44.4% of imports.

Ollen Pharma Trading Inc — Import Portfolio & Supplier Network

Ollen Pharma Trading Inc import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Ollen Pharma Trading Inc?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Althea Pharma Private Limited	$1.5M	333	44.4%
Bdh Industries Limited	$592.7K	19	18.1%
Vins International Private Limited	$379.9K

What Formulations Does Ollen Pharma Trading Inc Import?

Formulation	Value	Ships
Relax-saph(ipratropium bromide	$113.5K	20
Pharmaceutical products, pantozisaph pantoprazole + domperidonecapsules 40 mg30 MG Pack of 63000 x 3 x 10	$83.0K	3
Pharmaceutical products deoxysaph	$80.3K	2
Pharmaceutical products-harmless medicine saphzar 80 (valsartan tablets USP 80 MG)	$76.9K	3
Pharmaceutical products-harmless medicine saphzar 160 (valsartan tablets USP 160MG)	$71.0K	3
Pharmaceutical products-harmless medicine for human consumption carvesaph -25 (carvedilol tablets USP 25 MG)	$55.5K	3
Pharmaceutical products-harmless medicine for human consumption tamsusaph-400 (tamsulosin hydrochloride tablets 400 MCG)	$54.1K	3
Pharmaceutical products hesminsaph-500	$53.1K	2
Deoxysaph(ursodeoxychlolic acid 250 MG	$50.0K	1
Deoxysaph(ursodeoxychlolic acid 300 MG	$50.0K	1
Pharmaceutical products deoxysaph	$50.0K	1
Pharmaceutical article / ods / product / item urodil	$50.0K	1
Hesminsaph-500 diosmin + hesperidin	$50.0K	1
Pharmaceutical products harmless medicine, saphzimet(gliclazide & metformin hydrochloride (Pack of 9700 x3x10 t)	$50.0K	1
Pharmaceutical products harmless medicine-pantozisaph (pantoprazole+domperidonecapsules 40 MG/30 MG)(Pack of 3 x 10 c)	$50.0K	1

Ollen Pharma Trading Inc imports 224 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Ipratropium	Respiratory	$685.5K	174	1.2%	7
2	Carvedilol	Cardiovascular	$650.0K	13	0.7%	17
3	Domperidone	Gastrointestinal	$350.0K	7	1.2%	4
4	Febuxostat	Lipid & Metabolism	$200.0K	4	0.4%	19

Ollen Pharma Trading Inc imports 4 pharmaceutical products across 4 categories into Philippines totaling $1.9M.

Ollen Pharma Trading Inc — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Ollen Pharma Trading Inc is a pharmaceutical importer based in Paranaque City, Philippines. The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $1.9 million USD over 198 shipments from 2022 to 2026, Ollen Pharma Trading Inc plays a significant role in the Philippine pharmaceutical distribution network. The company's product portfolio spans four therapeutic categories, with a concentration in respiratory, cardiovascular, and gastrointestinal medications.

2Distribution Network

While specific details about Ollen Pharma Trading Inc's warehouse locations and logistics capabilities are not publicly disclosed, the company's substantial import volume suggests a well-established distribution network within the Philippines. The focus on sourcing from India indicates a strategic approach to leverage cost-effective and high-quality pharmaceutical products. The company's operations likely cover major urban centers and healthcare facilities across the Philippines, ensuring widespread availability of imported medications.

3Industry Role

Ollen Pharma Trading Inc functions as a primary wholesaler in the Philippine pharmaceutical supply chain. By importing a diverse range of finished pharmaceutical formulations, the company supplies these products to various stakeholders, including hospitals, clinics, and retail pharmacies. This role is crucial in bridging the gap between international manufacturers and the local healthcare market, ensuring the availability of essential medications to meet public health needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Ollen Pharma Trading Inc

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy is heavily concentrated on a select group of Indian suppliers, with the top five suppliers accounting for 100% of the import value. This indicates a strategic choice to establish strong, reliable partnerships with these suppliers. The high number of shipments from these suppliers suggests a stable and consistent relationship, which is beneficial for maintaining product quality and supply chain reliability. However, such concentration also poses a risk; any disruption with these suppliers could significantly impact Ollen Pharma Trading Inc's operations.

2Supply Chain Resilience

Ollen Pharma Trading Inc's supply chain resilience appears robust, given the extensive number of shipments from its top suppliers. The diversity of formulations imported indicates a broad product range, which can mitigate risks associated with dependency on a single product line. However, the reliance on a limited number of suppliers from India means that any disruptions—such as regulatory changes, logistical challenges, or geopolitical issues—could affect the company's ability to maintain a steady supply of medications. Ensuring compliance with international quality standards, such as WHO Good Manufacturing Practices (GMP), is essential for maintaining product quality and regulatory compliance.

Strategic Implications

Importing Pharmaceuticals into Philippines — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Philippines

1Regulatory Authority & Framework

The Food and Drug Administration (FDA) of the Philippines is the primary regulatory body overseeing the importation and distribution of pharmaceutical products. The FDA operates under the Department of Health (DOH) and is responsible for ensuring the safety, efficacy, and quality of drugs entering the country. Key legislation governing pharmaceutical imports includes the FDA Act of 2009 (Republic Act No. 9711) and the Food, Drugs, and Devices Act (Republic Act No. 3720). These laws mandate that all pharmaceutical products must be registered with the FDA before they can be imported, sold, or distributed in the Philippines. The registration process involves submitting comprehensive documentation, including product information, manufacturing details, and evidence of compliance with Good Manufacturing Practices (GMP).

2Import Licensing & GMP

Importers like Ollen Pharma Trading Inc must secure a License to Operate (LTO) from the FDA, which authorizes them to import pharmaceutical products. Additionally, the FDA requires that imported pharmaceutical products be registered, ensuring they meet the necessary safety and efficacy standards. The FDA recognizes GMP certificates from reputable authorities, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), facilitating the importation of products manufactured under these standards. Importers must also obtain wholesale distribution authorization, which permits them to distribute pharmaceutical products within the country.

Ollen Pharma Trading Inc — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Ollen Pharma Trading Inc's focus on importing respiratory, cardiovascular, and gastrointestinal medications aligns with the prevalent health concerns in the Philippines. Respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), are common, necessitating a steady supply of inhalers and bronchodilators. Cardiovascular diseases, including hypertension and heart failure, are leading causes of morbidity and mortality, driving demand for related medications. Gastrointestinal disorders, such as acid reflux and irritable bowel syndrome, also contribute to the need for effective treatments. By concentrating on these therapeutic areas, Ollen Pharma Trading Inc addresses critical healthcare needs and positions itself as a key supplier of essential medications in the Philippine market.

2Sourcing Profile

Ollen Pharma Trading Inc's sourcing strategy emphasizes importing generic drugs from India, leveraging cost-effective manufacturing and a wide range of available formulations. The company's preference for finished pharmaceutical formulations indicates a focus on ready-to-market products, reducing the time and resources required for product development and registration. India's compliance with international quality standards, such as WHO GMP, ensures that the imported products meet the necessary safety and efficacy criteria. This approach allows Ollen Pharma Trading Inc to offer a diverse product portfolio while maintaining cost competitiveness in the Philippine market.

Seller's Guide — How to Become a Supplier to Ollen Pharma Trading Inc

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Ollen Pharma Trading Inc, given the company's substantial import volume and focus on sourcing from India. Suppliers that can offer high-quality products, adhere to international manufacturing standards, and provide reliable delivery schedules may find a receptive partner in Ollen Pharma Trading Inc. Additionally, exploring partnerships with other pharmaceutical importers in the Philippines could open new market avenues and increase overall market share. However, potential suppliers should be prepared to meet the regulatory requirements set by the Philippine FDA and ensure compliance with local labeling and quality standards.

2Requirements & Qualifications

Indian exporters seeking to supply Ollen Pharma Trading Inc and the Philippine market must ensure that their products are registered with the Philippine FDA and comply with the necessary quality standards, such as WHO GMP or PIC/S certifications. Importers must secure a License to Operate (LTO) from the FDA, which authorizes them to import pharmaceutical products. Additionally, products must meet labeling requirements, including information in English and Filipino, and adhere to serialization mandates if applicable. Ensuring compliance with these regulations is essential for successful market entry and distribution in the Philippines.

Frequently Asked Questions — Ollen Pharma Trading Inc

What products does Ollen Pharma Trading Inc import from India?

Ollen Pharma Trading Inc imports 4 pharmaceutical products across 4 categories. Top imports: Ipratropium ($685.5K), Carvedilol ($650.0K), Domperidone ($350.0K), Febuxostat ($200.0K).

Who supplies pharmaceuticals to Ollen Pharma Trading Inc from India?

Ollen Pharma Trading Inc sources from 10 verified Indian suppliers. The primary supplier is Althea Pharma Private Limited (44.4% of imports, $1.5M).

What is Ollen Pharma Trading Inc's total pharmaceutical import value?

Ollen Pharma Trading Inc's total pharmaceutical import value from India is $1.9M, based on 198 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Ollen Pharma Trading Inc focus on?

Ollen Pharma Trading Inc imports across 4 categories. The largest: Respiratory (36.4%), Cardiovascular (34.5%), Gastrointestinal (18.6%).

Get Full Ollen Pharma Trading Inc Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.